Showing results (31-40 of 157) with videos related to
Sort By:
Pageof 16
Journal of Geriatric Oncology|March 15, 2018
The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancerAndrew J Benjamin, Mary M Buschmann, Shuang Qin Zhang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief reportArkadiusz Z Dudek, Herbert Pang, Robert A Kratzke, et al.Journal of Gastrointestinal Oncology|January 18, 2021
A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative dosesStanley L Liauw, Lisa Ni, Tianming Wu, et al.Investigational New Drugs|August 12, 2009
The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II ConsortiumHalla S Nimeiri, Deepti A Singh, Kristen Kasza, et al.Cancer Chemotherapy and Pharmacology|May 17, 2005
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancerApurva A Desai, Hedy L Kindler, David Taber, et al.Lung Cancer (Amsterdam, Netherlands)|December 7, 2007
Current state and future directions of pleural mesothelioma imagingSamuel G Armato, James Entwisle, Mylene T Truong, et al.The Annals of Thoracic Surgery|October 22, 2016
Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural MesotheliomaWickii T Vigneswaran, Diana Y Kircheva, Vijayalakshimi Ananthanarayanan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group BRamaswamy Govindan, Robert A Kratzke, James E Herndon, et al.Clinical Colorectal Cancer|January 7, 2011
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinomaAllyson J Ocean, Blase Polite, Paul Christos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancerSridhar Mani, Charles M Rudin, Katie Kunkel, et al.Pageof 16